PIK3CA kinase domain mutation identifies a subgroup of stage III colon cancer patients with poor prognosis

Author(s):
Sarasqueta, A.F.; Zeestraten, E.C.M.; Wezel, T. van; Lijnschoten, G. van; Eijk, R. van; Dekker, J.W.T.; Kuppen, P.J.K. (0000-0002-0294-3251); Goossens-Beumer, I.J.; Lemmens, V.E.P.P.; Velde, C.J.H. van de (0000-0003-0104-1800); Rutten, H.J.T.; Morreau, H.; Brule, A.J.C. van den
Published
2011
Publication type
Article / Letter to editor
Colon carcinomaPIK3CA mutationsPrognostic factorBiomarkers
Date issued
2011-12-31
Language
English
Is part of
Cellular Oncology (2011), Vol. 34, no. 6, p. 523-531
hdl
1887/106176
doi
10.1007/s13402-011-0054-4